Skip to main content

Kalehua Capital Management LLC

13F filer · CIK 0002106181
Reported Aug 19, 2026
Net buyer this quarter
13F portfolio value$313MU.S. long equity reported on 13F
Positions258 new · 7 closed
Net flow last quarter+$50.9MBuys minus sells
Top 10 positions weight65.8%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 19, 202625 positions
MANEVeradermics, Inc$35.8M11.43%0.70%+17.2%Q1 2026
XFORX4 Pharmaceuticals, Inc$34.8M11.09%7.75%Not reportedQ4 2025
CMPSCOMPASS Pathways plc$23.2M7.40%1.21%Not reportedQ4 2025
SRZNSurrozen, Inc.$20M6.38%6.55%Not reportedQ4 2025
ACRSAclaris Therapeutics, Inc.$19.4M6.18%2.62%+15.6%Q1 2026
SIONSionna Therapeutics, Inc.$17.3M5.53%0.87%Not reportedQ4 2025
IKTInhibikase Therapeutics, Inc.$15.5M4.95%5.79%+17.7%Q4 2025
PHVSPharvaris N.V.$13.7M4.39%0.61%Not reportedQ4 2025
KPTIKaryopharm Therapeutics Inc.$13.4M4.27%6.05%NewQ2 2026
SEPNSepterna, Inc.$13M4.16%0.85%Not reportedQ4 2025
IFRXInflaRx N.V.$13M4.14%8.02%NewQ2 2026
CYCNCyclerion Therapeutics, Inc.$11.2M3.57%77.60%NewQ2 2026
QUREuniQure N.V.$7.31M2.33%0.23%-68.4%Q1 2026
LONALeonaBio, Inc.$7.24M2.31%8.36%Not reportedQ4 2025
DMRADamora Therapeutics, Inc.$7.23M2.31%0.45%Not reportedQ1 2026
MLTXMoonLake Immunotherapeutics$6.84M2.18%0.48%Not reportedQ4 2025
KRROKorro Bio, Inc.$5.34M1.70%2.75%+270.3%Q1 2026
TYRATyra Biosciences, Inc.$4.76M1.52%0.25%Not reportedQ4 2025
NVCTNuvectis Pharma, Inc.$3.68M1.17%0.75%NewQ2 2026
GOSSGossamer Bio, Inc.$3.67M1.17%4.56%+25.9%Q1 2026
MISTMilestone Pharmaceuticals Inc.$3.4M1.09%2.04%NewQ2 2026
ANLAdlai Nortye Ltd.$2.6M0.83%Not reportedNewQ2 2026
ATYRaTYR PHARMA INC$2.13M0.68%3.65%NewQ2 2026
TILInstil Bio, Inc.$1.53M0.49%2.94%-38.3%Q1 2026
TCRXTScan Therapeutics, Inc.$892K0.28%3.79%NewQ2 2026
Q1 2026Reported May 15, 202624 positions
XFORX4 Pharmaceuticals, Inc$30.8M11.83%7.89%+100.0%Q4 2025
SRZNSurrozen, Inc.$22.4M8.63%6.70%+100.0%Q4 2025
RLAYRelay Therapeutics, Inc.$17.9M6.90%0.95%+100.0%Q4 2025
SIONSionna Therapeutics, Inc.$15.8M6.08%0.87%+100.0%Q4 2025
MANEVeradermics, Inc$15.7M6.04%0.67%NewQ1 2026
ACRSAclaris Therapeutics, Inc.$11.9M4.57%2.27%NewQ1 2026
ORKAOruka Therapeutics, Inc.$11.6M4.47%0.47%+100.0%Q4 2025
PHVSPharvaris N.V.$11.2M4.32%0.61%+100.0%Q4 2025
IKTInhibikase Therapeutics, Inc.$10.9M4.20%4.92%+271.1%Q4 2025
SEPNSepterna, Inc.$9.35M3.60%0.87%+100.0%Q4 2025
CMPSCOMPASS Pathways plc$9.07M3.49%1.22%+100.0%Q4 2025
QUREuniQure N.V.$8.22M3.16%0.80%NewQ1 2026
LONALeonaBio, Inc.$8.09M3.11%8.38%+100.0%Q4 2025
DMRADamora Therapeutics, Inc.$7.2M2.77%0.46%NewQ1 2026
MLTXMoonLake Immunotherapeutics$6.55M2.52%0.67%+100.0%Q4 2025
GOSSGossamer Bio, Inc.$5.82M2.24%7.55%NewQ1 2026
TYRATyra Biosciences, Inc.$5.7M2.19%0.25%+100.0%Q4 2025
PEPGPepGen Inc.$3.06M1.18%2.50%NewQ1 2026
TNYATenaya Therapeutics, Inc.$2.77M1.07%1.84%+100.0%Q4 2025
TILInstil Bio, Inc.$2.66M1.02%4.76%NewQ1 2026
KLRSKalaris Therapeutics, Inc.$1.56M0.60%1.18%+93.8%Q4 2025
KRROKorro Bio, Inc.$1.24M0.48%0.76%NewQ1 2026
DMACDiaMedica Therapeutics Inc.$846K0.33%0.23%+31.1%Q4 2025
LOOPLoop Industries, Inc.$361K0.14%0.72%NewQ1 2026
Q4 2025Reported Feb 13, 202618 positions
XFORX4 Pharmaceuticals, Inc$14.9M14.73%4.10%NewQ4 2025
SIONSionna Therapeutics, Inc.$8.11M8.02%0.44%NewQ4 2025
RLAYRelay Therapeutics, Inc.$7.63M7.54%0.52%NewQ4 2025
CMPSCOMPASS Pathways plc$5.66M5.59%0.85%NewQ4 2025
PHVSPharvaris N.V.$5.52M5.46%0.30%NewQ4 2025
SEPNSepterna, Inc.$5.42M5.36%0.43%NewQ4 2025
ORKAOruka Therapeutics, Inc.$3.59M3.55%0.24%NewQ4 2025
IKTInhibikase Therapeutics, Inc.$3.59M3.55%1.33%NewQ4 2025
ALLOAllogene Therapeutics, Inc.$3.49M3.45%1.11%NewQ4 2025
LONALeonaBio, Inc.$2.98M2.95%4.22%NewQ4 2025
MLTXMoonLake Immunotherapeutics$2.32M2.29%0.33%NewQ4 2025
ORICOric Pharmaceuticals, Inc.$2.18M2.16%0.27%NewQ4 2025
VRCAVerrica Pharmaceuticals Inc.$1.96M1.94%1.37%NewQ4 2025
TYRATyra Biosciences, Inc.$1.96M1.94%0.14%NewQ4 2025
SRZNSurrozen, Inc.$1.89M1.87%3.94%NewQ4 2025
TNYATenaya Therapeutics, Inc.$1.42M1.41%0.92%NewQ4 2025
KLRSKalaris Therapeutics, Inc.$1.18M1.17%0.61%NewQ4 2025
DMACDiaMedica Therapeutics Inc.$759K0.75%0.18%NewQ4 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.